— Know what they know.
Not Investment Advice

600535.SS SHH

Tasly Pharmaceutical Group Co., Ltd
1W: +0.4% 1M: -4.6% 3M: +1.7% YTD: -6.4% 1Y: -12.0% 3Y: +10.8% 5Y: +19.4%
¥14.00 ($2.09)
+0.26 (+1.89%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 37 · ¥20.9B mcap · 736M float · 1.99% daily turnover

📊 Key Metrics

TTM
¥8B
Revenue
-3.2% YoY
¥1B
Net Income
+14.6% YoY
¥2B
Free Cash Flow
+26.1% YoY
70.7%
Gross Margin
28.8%
Op. Margin
25.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE9.6%
ROA7.9%
ROIC11.9%

Valuation

P/E1.6
P/B0.1
EV/EBITDA-1.4

Leverage

Debt/Equity0.05
Current Ratio4.85
Interest Cov.82.2x

Quality Scores

Piotroski F8/9
Altman Z2.48
Beneish M-2.03

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms